Fulcrum Therapeutics, Inc.
NASDAQ:FULC
3.45 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 80 | 0 | 0.871 | 0.759 | 0.88 | 0.295 | 0.685 | 1.183 | 1.882 | 2.592 | 5.058 | 4.935 | 4.381 | 4.789 | 4.225 | 1.848 | 2 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.4 | 0.479 | 0.508 | 0.5 | 0.6 | 0.566 | 0.591 | 0.6 | 25.019 | 0.536 | 0.621 | 17.077 | 17.378 | 16.334 | 18.868 | 14.861 | 12.775 | 14.482 | 9.84 | 13.496 | 10.86 | 34.629 | 0 | 0 | 0 | 0 |
| Gross Profit
| 79.6 | -0.479 | 0.363 | 0.259 | 0.28 | -0.271 | 0.094 | 0.583 | -23.137 | 2.056 | 4.437 | -12.142 | -12.997 | -11.545 | -14.643 | -13.013 | -10.775 | -13.732 | -9.84 | -13.496 | -10.86 | -34.629 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.995 | 0 | 0.417 | 0.341 | 0.318 | -0.919 | 0.137 | 0.493 | -12.294 | 0.793 | 0.877 | -2.46 | -2.967 | -2.411 | -3.466 | -7.042 | -5.388 | -18.309 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 16.861 | 19.294 | 18.999 | 18.238 | 17.849 | 16.715 | 18.566 | 15.366 | 25.019 | 17.831 | 18.912 | 17.077 | 17.378 | 16.334 | 16.145 | 15.64 | 12.775 | 14.482 | 12.087 | 13.496 | 10.86 | 34.629 | 6.86 | 6.963 | 5.788 | 5.573 |
| General & Administrative Expenses
| 10.247 | 10.061 | 9.864 | 9.961 | 10.323 | 11.52 | 10.13 | 9.707 | 11.098 | 10.759 | 9.705 | 8.628 | 6.685 | 5.498 | 5.867 | 5.312 | 5.149 | 5.064 | 4.403 | 3.51 | 2.634 | 2.598 | 2.391 | 2.125 | 2.061 | 1.737 |
| Selling & Marketing Expenses
| 0.271 | 0 | -0.508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.247 | 10.061 | 9.356 | 9.961 | 10.323 | 11.52 | 10.13 | 9.707 | 11.098 | 10.759 | 9.705 | 8.628 | 6.685 | 5.498 | 5.867 | 5.312 | 5.149 | 5.064 | 4.403 | 3.51 | 2.634 | 2.598 | 2.391 | 2.125 | 2.061 | 1.737 |
| Other Expenses
| 2.917 | 2.964 | 3.236 | 3.423 | 3.509 | 3.161 | 1.838 | 0.617 | 0.165 | 0.07 | 0.075 | 0.054 | 0.034 | 0.044 | 0.067 | 0.142 | 0.239 | 0.344 | 0.007 | 0.007 | 0.008 | 0.007 | 0.007 | 0.007 | 0.008 | 0.37 |
| Operating Expenses
| 27.108 | 29.355 | 28.355 | 28.199 | 28.172 | 28.235 | 28.696 | 25.073 | 36.117 | 28.59 | 28.617 | 25.705 | 24.063 | 21.832 | 22.012 | 20.952 | 17.924 | 19.546 | 16.49 | 17.006 | 13.494 | 37.227 | 9.251 | 9.088 | 7.849 | 7.31 |
| Operating Income
| 52.492 | -29.834 | -27.992 | -27.44 | -27.292 | -27.94 | -27.973 | -24.355 | -34.235 | -25.998 | -23.559 | -20.77 | -19.682 | -17.043 | -17.787 | -19.104 | -15.924 | -18.796 | -16.49 | -17.006 | -13.494 | -37.227 | -9.251 | -9.088 | -7.849 | -7.31 |
| Operating Income Ratio
| 0.656 | 0 | -32.138 | -36.153 | -31.014 | -94.712 | -40.836 | -20.587 | -18.191 | -10.03 | -4.658 | -4.209 | -4.493 | -3.559 | -4.21 | -10.338 | -7.962 | -25.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.917 | 2.964 | 3.236 | 3.423 | 3.509 | 3.161 | 1.838 | 0.617 | 0.165 | 0.07 | 0.075 | 0.054 | 0.034 | 0.044 | 0.067 | 0.142 | 0.239 | 0.344 | 0.007 | 0.007 | 0.008 | 0.007 | 0.007 | 0.007 | 0.008 | 0.37 |
| Income Before Tax
| 55.409 | -26.87 | -24.756 | -24.017 | -23.783 | -24.779 | -26.135 | -23.738 | -34.07 | -25.928 | -23.484 | -20.716 | -19.648 | -16.999 | -17.72 | -18.962 | -15.685 | -18.452 | -16.123 | -16.542 | -13.169 | -36.843 | -8.859 | -8.943 | -7.846 | -6.94 |
| Income Before Tax Ratio
| 0.693 | 0 | -28.423 | -31.643 | -27.026 | -83.997 | -38.153 | -20.066 | -18.103 | -10.003 | -4.643 | -4.198 | -4.485 | -3.55 | -4.194 | -10.261 | -7.843 | -24.603 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.435 | 3.161 | 0.409 | 0.525 | -3.161 | -2.505 | 0.313 | -0.024 | -0.07 | -0.621 | 0.019 | -0.028 | 0 | -0.733 | 0 | 0 | 0 | -0.879 | -0.457 | -0.317 | -0.377 | -0.385 | -0.138 | 0.005 | 0 |
| Net Income
| 55.409 | -26.87 | -24.756 | -24.017 | -23.783 | -21.618 | -23.63 | -24.051 | -34.07 | -25.858 | -23.484 | -20.716 | -19.648 | -16.999 | -17.72 | -18.962 | -15.685 | -18.452 | -16.123 | -16.542 | -13.169 | -36.843 | -8.859 | -8.943 | -7.846 | -6.94 |
| Net Income Ratio
| 0.693 | 0 | -28.423 | -31.643 | -27.026 | -73.281 | -34.496 | -20.331 | -18.103 | -9.976 | -4.643 | -4.198 | -4.485 | -3.55 | -4.194 | -10.261 | -7.843 | -24.603 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.89 | -0.43 | -0.4 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.6 | -0.54 | -0.64 | -0.7 | -0.66 | -0.81 | -0.71 | -0.93 | -0.56 | -1.58 | -0.52 | -0.53 | -0.46 | -0.41 |
| EPS Diluted
| 0.87 | -0.43 | -0.4 | -0.39 | -0.38 | -0.36 | -0.45 | -0.52 | -0.83 | -0.64 | -0.58 | -0.57 | -0.6 | -0.54 | -0.64 | -0.7 | -0.66 | -0.81 | -0.71 | -0.93 | -0.56 | -1.58 | -0.52 | -0.53 | -0.46 | -0.41 |
| EBITDA
| 52.892 | -29.355 | -27.484 | -26.909 | -26.725 | -27.94 | -28.049 | -22.814 | -33.559 | -25.462 | -23.559 | -20.151 | -19.01 | -16.44 | -17.787 | -18.55 | -15.371 | -18.257 | -16.49 | -16.49 | -12.98 | -36.723 | -8.742 | -8.629 | -7.646 | -7.136 |
| EBITDA Ratio
| 0.661 | 0 | -31.555 | -35.453 | -30.369 | -94.712 | -40.947 | -19.285 | -17.832 | -9.823 | -4.658 | -4.083 | -4.339 | -3.433 | -4.21 | -10.038 | -7.686 | -24.343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |